| Rank | Ticker | Exchange | Price | Market Cap | 52W High | 52W Low | Analyst Rating |
|---|---|---|---|---|---|---|---|
#1 | COST | Nasdaq | $1,091.30 | $466.9B | $1,123.67 | $844.06 | Buy |
#2 | PG | Nasdaq | $168.60 | $346.1B | $173.59 | $137.62 | Buy |
#3 | DIS | Nasdaq | $121.06 | $178.6B | $122.72 | $92.19 | Buy |
#4 | IBN | Nasdaq | $35.14 | $102.4B | $35.07 | $25.08 | Strong Buy |
#5 | TGT | Nasdaq | $167.45 | $72.5B | $170.75 | $84.24 | Buy |
#6 | LH | Nasdaq | $368.94 | $30.2B | $375.10 | $245.00 | Buy |
#7 | DGX | Nasdaq | $259.12 | $25.9B | $263.19 | $171.18 | Buy |
#8 | DRI | Nasdaq | $231.87 | $22.4B | $236.78 | $169.53 | Buy |
#9 | RGA | Nasdaq | $268.96 | $17.7B | $277.15 | $184.78 | Buy |
#10 | BJ | Nasdaq | $110.67 | $13.3B | $113.35 | $83.21 | Buy |
#11 | R | Nasdaq | $284.16 | $10.2B | $291.03 | $161.89 | Buy |
#12 | CHE | Nasdaq | $549.86 | $6.7B | $562.24 | $365.21 | Buy |
#13 | TFX | Nasdaq | $164.48 | $6.1B | $162.41 | $100.18 | Buy |
#14 | CROX | Nasdaq | $160.05 | $5.8B | $164.24 | $75.13 | Buy |
#15 | BILL | Nasdaq | $65.13 | $4.5B | $66.54 | $31.41 | Buy |
#16 | TNL | Nasdaq | $78.88 | $3.9B | $81.00 | $60.98 | Strong Buy |
#17 | EXPO | Nasdaq | $88.55 | $3.1B | $90.51 | $51.91 | Buy |
#18 | VCEL | Nasdaq | $58.20 | $2.1B | $59.75 | $28.95 | Strong Buy |
#19 | WWW | Nasdaq | $25.48 | $1.6B | $25.60 | $14.00 | Buy |
#20 | UPBD | Nasdaq | $25.63 | $1.4B | $26.05 | $14.98 | Buy |
#21 | FENC | Nasdaq | $13.50 | $366.8M | $13.85 | $5.65 | Strong Buy |
The FinQuota filters have identified what they believe to be the "NASDAQ 52 Week High Stocks (November 19, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.